JPS6361952B2 - - Google Patents
Info
- Publication number
- JPS6361952B2 JPS6361952B2 JP56054824A JP5482481A JPS6361952B2 JP S6361952 B2 JPS6361952 B2 JP S6361952B2 JP 56054824 A JP56054824 A JP 56054824A JP 5482481 A JP5482481 A JP 5482481A JP S6361952 B2 JPS6361952 B2 JP S6361952B2
- Authority
- JP
- Japan
- Prior art keywords
- culture
- methanol
- streptomyces
- properties
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000000049 pigment Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 241000187747 Streptomyces Species 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 238000000862 absorption spectrum Methods 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000187179 Streptomyces tendae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 241000544912 Melanoides Species 0.000 description 1
- 244000038561 Modiola caroliniana Species 0.000 description 1
- 235000010703 Modiola caroliniana Nutrition 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241001600132 Streptomyces cyanogenus Species 0.000 description 1
- 241000122969 Streptomyces nodosus Species 0.000 description 1
- 241000946736 Streptomyces violaceolatus Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- YEESUBCSWGVPCE-UHFFFAOYSA-N azanylidyneoxidanium iron(2+) pentacyanide Chemical compound [Fe++].[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N#[O+] YEESUBCSWGVPCE-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229960002460 nitroprusside Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- -1 subsulfate Chemical compound 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Description
本発明はDC−52およびその製造法に関する。
本発明のDC−52は、各種の菌に抗菌作用を有
し、さらに抗腫瘍作用を有する有用な物質であ
る。
本発明者らは新規な抗性物質を開発する目的で
天然界より数多くの微生物を入手して抗生物質の
生産性を調べた。
その結果、東京都町田市内の土壌から分離した
菌株(DO−52と称する)を培地中の培養すると
培養物中に新規な抗生物質(DC−52)が生産さ
れることを見出した。
以下に発明を詳細に説明する。
本発明に係るDC−52の理化学的性質は次の通
りである。
元素分析値:
C:65.7% H:6.5% N:8.4%
分子式:C18H22N2O4
分子量:330(フイールドデイソープシヨン質
量分析)
融点:明確な融点はなく、170℃付近から
除々に褐変。
紫外部吸収スペクトル(水中):第1図
赤外部吸収スペクトル(KBr錠剤法):第2
図
比旋光度:〔α〕30 D=−41゜(c=0.35メタノー
ル)
PMRスペクトル(D2O中):第3図
CMRスペクトル(D2O中ジオキサン基準)
(ppm):180.2,156.5,137.1,128.9,123.3,
121.2,110.2,82.2,71.9,69.9,66.1,56.3,
54.4,53.9,41.6,40.4,32.0,27.6
溶解性:水,メタノール、エタノール,n−
ブタノールによくとける。酢酸エチル,アセト
ンにとける。クロロホルム,ベンゼン,n−ヘ
キサンにはほとんどとけない。
DO−52は発酵ブロス中にDC−52と共にDC−
52−dを併産する。DC−52−dはその後の検討
によりDC−52をパラジウム触媒存在下水素添加
することによつても得られるものであることが判
明した。DC−52−dの理化学的性質は次の通り
であり、紫外部吸収曲線はDC−52とほとんど同
一である。またPMRスペクトルも共通するとこ
ろが多く両者は互に関連あることを示している。
DC−52−dの物理化学的性質
分子量:332(フイールドデイソープシヨン質
量分析でm/e333(M+1)を与えた。)
分子式:C18H24N2O4
融点:明確な融点はなく、190℃付近から
除々に褐変する。
紫外部吸収スペクトル(メタノール中):
280nmおよび273nmに吸収極大を示す。
PMRスペクトル(D2O中):第4図
次に、DC−52およびDC−52−dの薄層クロマ
トグラフイー(シリカゲル(商品名
Kieselgel60Art.5721,E.Merck西独)を用い、
室温で3時間展開する。〕でのRf値は第1表の通
りである。
The present invention relates to DC-52 and its manufacturing method. DC-52 of the present invention is a useful substance that has antibacterial activity against various bacteria and also has antitumor activity. In order to develop new antibiotic substances, the present inventors obtained a large number of microorganisms from nature and investigated their antibiotic productivity. As a result, they discovered that when a bacterial strain isolated from soil in Machida City, Tokyo (referred to as DO-52) was cultured in a culture medium, a novel antibiotic (DC-52) was produced in the culture. The invention will be explained in detail below. The physical and chemical properties of DC-52 according to the present invention are as follows. Elemental analysis value:
C: 65.7% H: 6.5% N: 8.4% Molecular formula: C 18 H 22 N 2 O 4 Molecular weight: 330 (field day soap mass spectrometry) Melting point: There is no clear melting point, and it gradually turns brown from around 170°C. Ultraviolet absorption spectrum (in water): Figure 1 Infrared absorption spectrum (KBr tablet method): Figure 2
Figure Specific rotation: [α] 30 D = -41° (c = 0.35 methanol) PMR spectrum (in D 2 O): Figure 3 CMR spectrum (dioxane standard in D 2 O)
(ppm): 180.2, 156.5, 137.1, 128.9, 123.3,
121.2, 110.2, 82.2, 71.9, 69.9, 66.1, 56.3,
54.4, 53.9, 41.6, 40.4, 32.0, 27.6 Solubility: water, methanol, ethanol, n-
Soluble in butanol. Dissolves in ethyl acetate and acetone. Almost insoluble in chloroform, benzene, and n-hexane. DO−52 is DC−52 along with DC−52 in fermentation broth.
Co-produces 52-d. Subsequent studies revealed that DC-52-d can also be obtained by hydrogenating DC-52 in the presence of a palladium catalyst. The physical and chemical properties of DC-52-d are as follows, and its ultraviolet absorption curve is almost the same as that of DC-52. Furthermore, there are many common PMR spectra, indicating that the two are related to each other. Physicochemical properties of DC-52-d Molecular weight: 332 (m/e333 (M+1) was given by field day soap mass spectrometry.) Molecular formula: C 18 H 24 N 2 O 4 Melting point: There is no clear melting point, It gradually turns brown from around 190℃. Ultraviolet absorption spectrum (in methanol):
Shows absorption maximum at 280nm and 273nm. PMR spectrum (in D 2 O): Figure 4 Next, thin layer chromatography (silica gel (trade name) of DC-52 and DC-52-d)
Kieselgel60Art.5721, E.Merck (West Germany),
Develop for 3 hours at room temperature. ] The Rf values are shown in Table 1.
【表】
展開後DC−52およびDC−52−dのスポツト
は、Bacillus subtilsを用いるバイオアツセイ,
熱硫酸,沃素,ニトロプルシツド反応、ニンヒド
リン反応、エールリツヒ試薬,トラーゲンドルフ
反応および紫外部吸収により検出できる。
上記の理化学的性質を有するDC−52およびDC
−52−dは文献未記載の新規物質ある。
尚、上記理化学的性質およびX線結晶学研究に
基づき、DC−52およびDC−52−dはそれぞれ次
の構造式を有することが判明した。
DC−52の構造式:
DC−52−dの構造式:
次にDC−52およびDC−52−dの各種細菌に対
する抗菌活性(寒天希釈法,PH7・0)を示す
と、第2表の通りである。[Table] After development, the spots of DC-52 and DC-52-d were determined by bioassay using Bacillus subtils,
It can be detected using hot sulfuric acid, iodine, nitroprusside reaction, ninhydrin reaction, Ehrlich reagent, Tragendorf reaction, and ultraviolet absorption. DC-52 and DC with the above physical and chemical properties
-52-d is a new substance that has not been described in any literature. Based on the above-mentioned physical and chemical properties and X-ray crystallography studies, it has been found that DC-52 and DC-52-d each have the following structural formulas. Structural formula of DC-52: Structural formula of DC-52-d: Next, Table 2 shows the antibacterial activity of DC-52 and DC-52-d against various bacteria (agar dilution method, pH 7.0).
【表】
またDC−52の急性毒性値(LD50)はマウスへ
の腹腔内投与で約180Kg/Kgであつた。
次にDC−52の抗腫瘍作用を示す。
(1) サルコーマ180腹水型腫瘍に対する治療効果
体重約20gのddy雄マウス1群6匹にサルコー
マ180腹水型腫瘍細胞5×106個を腋窩部皮下に移
植した。移植後24時間目に各種濃度のDC−52の
燐酸緩衝液生理食塩水(PBS)溶液0.2mlを1回
腹腔内に投与した。PBSの組成はNaCl0.8g/
dl,KCl0.02g/dl,Na2HPO41.15g/dl,
KH2PO40.02g/dl,PH7.2のものである。比較例
として腫瘍細胞移植後24時間目にマイトマイシン
Cを含むPBS0.2mlを腹腔内に投与した群を設け
た。移植10日後の平均腫瘍体積(mm3)および
T/C(T:試験例の平均腫瘍体積、C:PBS0.2
mlを腹腔内投与したもの)の平均腫瘍体積)を測
定し、第3表に示す結果を得た。[Table] Furthermore, the acute toxicity value (LD 50 ) of DC-52 was approximately 180 Kg/Kg when administered intraperitoneally to mice. Next, we will show the antitumor effect of DC-52. (1) Therapeutic effect on Sarcoma 180 ascites-type tumor 5 x 10 6 cells of Sarcoma 180 ascites-type tumor were subcutaneously implanted in the axillary region of 1 group of 6 DDY male mice weighing approximately 20 g. Twenty-four hours after transplantation, 0.2 ml of DC-52 at various concentrations in phosphate buffered saline (PBS) was intraperitoneally administered once. The composition of PBS is NaCl0.8g/
dl, KCl0.02g/dl, Na 2 HPO 4 1.15g/dl,
KH 2 PO 4 0.02g/dl, PH7.2. As a comparative example, a group was provided in which 0.2 ml of PBS containing mitomycin C was intraperitoneally administered 24 hours after tumor cell transplantation. Average tumor volume (mm 3 ) and T/C 10 days after transplantation (T: average tumor volume of test example, C: PBS0.2
The average tumor volume (intraperitoneally administered) was measured, and the results shown in Table 3 were obtained.
【表】
(2) リンホサイテイツク・リユケミアP−388腫
瘍に対する治療効果
体重約22gのCDF1雄マウス1群5匹に、リン
ホサイテイツク・リユケミア
(Lymphocyticleukemia)P−388腫瘍細胞1×
106個を腹腔内移植した。移植後24時間目にDC−
52のPBS溶液0.2mlを1回腹腔内に投与した比較
例として、腫瘍細胞移植後24時間目にマイトマイ
シンCのPBS溶液0.2mlを腹腔内投与した群を設
けた。移植後の平均生存日数及びT/C(T:試
験例の平均生存日数、C:対照の平均生存日数)
を第4表に示す。[Table] (2) Therapeutic effect on Lymphocyticleukemia P-388 tumor Lymphocyticleukemia P-388 tumor cells 1× were injected into groups of 5 CDF 1 male mice weighing approximately 22 g.
10 6 were implanted intraperitoneally. DC− 24 hours after transplantation
As a comparative example, a group was prepared in which 0.2 ml of mitomycin C in PBS was intraperitoneally administered 24 hours after tumor cell transplantation. Average survival days and T/C after transplantation (T: average survival days of test cases, C: average survival days of controls)
are shown in Table 4.
【表】
次にDC−52製造法について説明する。
DC−52はストレプトマイセス属に属し、DC−
52を生産する能力を有する微生物を培地に培養
し、DC−52を培養中に蓄積せしめ、該培養物か
らDC−52を採取することによつて得ることがで
きる。
本発明において使用する微生物はストレプトマ
イセス属に属し、DC−52を生産する能力を有す
る微生物であればいずれの微生物も用いることが
できる。好適な菌としては前記DO−52株があげ
られる。
次にDO−52株の菌学的性質について記述す
る。
(A) 形態的性質
DO−52株は一般の分離用培地で気菌糸を良好
に着生し、その形態は単純分枝で曲状(フレキシ
ヤス)〜らせん型(スパイラル)である。胞子は
10個以上連鎖し、表面に滑らか(スムーズ)であ
る。胞子の形状は円筒形(約0.4×0.6μ)である。
DO−52株を各種培地上で生育させたときの生
育状態、コロニーの表面および裏面の色、および
可溶性色素について第5表に示す。
色の表示はColor Harmony Manual
(Container Corporation of America)による
色の分類に従つたものである。[Table] Next, the DC-52 manufacturing method will be explained. DC-52 belongs to the genus Streptomyces, and DC-52 belongs to the genus Streptomyces.
DC-52 can be obtained by culturing a microorganism capable of producing 52 in a medium, allowing DC-52 to accumulate during the culture, and collecting DC-52 from the culture. The microorganism used in the present invention belongs to the genus Streptomyces, and any microorganism can be used as long as it has the ability to produce DC-52. A suitable bacterium is the above-mentioned strain DO-52. Next, the mycological properties of strain DO-52 will be described. (A) Morphological properties Strain DO-52 adheres well to aerial mycelia on a general isolation medium, and its morphology is simple branched and curved (flexible) to helical (spiral). The spores are
10 or more chains, and the surface is smooth. The shape of the spore is cylindrical (approximately 0.4 x 0.6μ). Table 5 shows the growth conditions, colors of the front and back surfaces of colonies, and soluble pigments when the DO-52 strain was grown on various media. Colors are displayed using the Color Harmony Manual
(Container Corporation of America) color classification.
【表】
(B) 生理的性質
DO−52株の生理的性質について以下に示す。
温度、ミルクおよび繊維素に対する作用以外の
ものについては27℃2週間後の観察結果を示し、
温度は5日後、ミルクおよび繊維素に対する作用
については1ケ月後の結果を示す。
1 炭素源の資化性
炭素源 資化性
D−アラビノース ±
D−キシロース +
D−グルコース
D−フラクトース
シユクロース +
イノシトール ±
L−ラムノース
ラフイノース +
D−マンニツト −
2 ゼラチンの液化 ±
3 ミルクに対する作用 液化〓
凝固−
ペプトン化−
4 繊維素の分解 わずかにある
5 殿粉の加水分解 ある
6 至適生育PH 6.8−7.5
7 至適生育温度 28−38℃
8 チロシナーゼの生成 なし
9 メラノイド色素の生成 なし
以上の性状からDO−52株はストレプトマイセ
ス層に属する放線菌に分類される。この菌の属す
る種に関して、E.Ku¨ster(Intern.J.System.
Bacteriol.,22巻No.3、139頁、1972)による分
類によれば、気菌糸が灰色系のものに入り、明確
な菌糸裏面の色(暗褐色〜黒色)がであり、メラ
ミン系色素を産生せず、可溶性色素があり、胞子
柄が曲状ないしらせん型のもので、表面が滑らか
なものとして以下の4種があげられる。
ストレプトマイセス・テンダエ
(Streptomyces tendae),ストレプトマイセス・
ノドサス(Streptomyces nodosus),ストレプト
マイセス・シアノゲナス(Streptomyces
cyanogenus),ストレプトマイセス・ビオラセオ
ラタス(Streptomyces violaceolatus)。
胞子柄の形状からは前二者に近いが、可溶性色
素および糖の資化性において異る。たとえばDO
−52では色素は酸性側で色の変化はなく、アルカ
リ側で変るのに対してそれら対象種の色素は酸性
側で色調が変化する。またラフイノース,マンニ
トールの資化性が逆である。
後二者は、胞子柄の形状はやゝ異るが、糖の資
化性はよく似ているが、マンニトール、イノシト
ールの資化性が異ること、可溶性色素が酸・アル
カリで変化するのに対して、DO−52の色素はア
ルカリ側で変化するのみである。
(E.B.Shirling and D.Gottlieb.Intern・J.
System.Bacteriol.,18(2)69( ′68),InternJ.
System.Bacteriol.,18(4)282( ′68),Intern.J.
System.Bacteriol.,19(4)391( ′69))
以上4種と比較して大きく異る点として、胞子
の形状が円筒型(約0.4×0.6μ)あることと、可
溶性色素の変化があげられる。とくにDO−52の
モーブワイン(7 1/2ni)は特徴的なものある。
これはNaOHでシナモン・ブラウン(3g)
に変化する。この黒紫色の色素は液体培養を行う
と菌体外に排出され培地中に蓄積する。
このような見地からDO−52は対象としてとり
あげたいずれの菌株とも異なる新種であると判定
し、その特徴的な産生色素に因んでストレプトマ
イセス・メラノビナセウス(Streptomyces
melanovinaceusDO−52)と命名した。
この菌は茨城県筑波郡谷田部町東1−1−3に
所在する工業技術院微生物工業技術研究所および
アメリカ合衆国イリノイ州ペオリアに所在する
U.S.Department of Agricultureにそれぞれ寄託
され、微工研条第654号およびNRRL12388の受
託番号が与えられている。
こゝに示した菌株はストレプトマイセス属に属
する既知菌種の場合にみられるように、その性状
が例えば紫外線、X線、薬品等の人工的変異手段
で変異することもあるが、このような変異株あつ
てもDC−52の生産能を有するのはすべて本発明
に適用できる。
次に培養法についてのべる。
本発明の培養においては通常の放線菌の培養法
が一般に用いられる。培養のための栄養源として
は下記に示すごとくいろいろのものが用いられ
る。炭素源としてはグルコース、殿粉、デキスト
リン,マンノース,フラクトース,シユークロー
ス,ラクトース,キシロース,アラビノース,マ
ンニトール,糖密などが単独または組み合わせて
用いられる。さらに、菌の資化能によつては炭化
水素,アルコール類,有機酸なども用いられる。
窒素源としては塩化アンモン,硫酸アンモン,硝
酸アンモン,硝酸ソーダ,尿素,ペプトン,肉エ
キス,酵母エキス,乾燥酵母,コーン,スチー
ブ,リカー、大豆粉,カザミノ酸などが単独また
は組み合わせて用いられる。そのほか、必要に応
じて食塩,塩化カリ,硫酸マグネシウム,炭酸カ
ルシウム,燐酸二水素カリウム,燐酸水素二カリ
ウム,硫酸第一鉄,塩化カルシウム,硫酸マンガ
ン,硫酸亜塩,硫酸銅などの無機塩類を加える。
さらに使用菌の生育やDC−52およびDC−52−d
の生産を促進する微量成分例えばビタミンB1、
ビオチンなどを適当に添加することができる。
培養法としては、液体培養法、とくに深部撹拌
培養法がもつとも適している。培養温度は25〜40
℃、特に28〜38℃が最適で、培地のPHはアンモニ
ア水や炭酸アンモン溶液などを添加して、PH4〜
10好ましくは6〜8で培養を行なうことが望まし
い。
液体培養で通常1日ないし7日培養を行なうと
目的物質(DC−52およびDC−52−d)が培養液
中および菌体中に生成蓄積される。培養物中の生
成量が最大に達したときに培養を停止し、菌体を
別し、培養液と菌体にわける。
培養液からのDC−52およびDC−52−dの単
離精製には、微生物代謝生産物を、その培養液か
ら単離するために用いられる通常の分離・精製法
が利用される。例えば、培養生産物を培養液と菌
体とに分離し、培養液はそのまま(PH6.0)非イ
オン性多孔性樹脂(たとえば、商品名「ダイヤイ
オンPH−20」三菱成社製など)を通過させ、活性
成分を吸着させた後、メタノール,アセトン,酢
酸エチルなどを用いて吸着物質を脱着させる。こ
の脱着液を濃縮乾固し、セライト粉末に吸着し、
メタノール、アセトンなどを用いてDC−52およ
びDC−52−dを脱着できる。さらに溶媒抽出法、
分配クロマト法など一般的精製法を組み合わせて
精製する。
次に実施例をあげる。
実施例中、DC−52およびDC−52−dの動向は
バチルス・ズブチリスNo.10707を用いるバイオア
ツセイ又はDC−52およびDC−52−dの紫外部吸
収を目安にして追跡した。
実施例 1
種菌としてストレプトマイセス・メレオビナセ
ウスDO−52を用いた。該菌株を2容量の三角
フラスコ中の種培地〔KCl4g/,MgSO4・
7H2O0.5g/、KH2PO41.5g/,硫安5.0
g/,シユークロース20g/,フラクトース
10g/,グルコース10g/,コーンスチーブ
リカー5.0g/,CaCO320g/PH7.0〕300ml
に植菌し、30℃で48時間振とう(220r.p.m.)培
養した。かくして得られた種培養液を30容量の
ジヤーフアーメンター中の下記組成の発酵培地15
に5%(容量)の割合で移し、30℃通気撹拌方
式(回転数250r.p.m.通気量15/min)により培
養を行つた。
発酵培地組成:グルコース50g/,
KH2PO40.3g/,K2HPO40.4g/,
MgSO4・7H2O0.2g/,粉末大豆粕20g/,
CaCO31g/,PH7.0(殺菌前)にNaOHで調整
する。
培養中培地のPHは制御しないで、72時間培養す
る。培養液より菌体および沈殿物を別し、液
13を得る。まず液を陽イオン交換樹脂WK−
20(三菱化成社製)500mlに通塔して活性物質を吸
着させ水で充分に洗う。次いで2Mの酢酸アンモ
ニウム水溶液3で溶出し、溶出液はそのまま
500mlの非イオン性多孔性樹脂(ダイヤイオン
HP−20,三菱化成社製)に通塔して活性物質を
吸着させ水2,20%メタノール2で洗つた後
50%メタノール3で活性物質を溶出する。溶出
液に活性炭3gを加えて脱色した後、活性炭を
別する。これを濃縮してメタノールを除去し、次
いで400mlの非イオン性多孔性樹脂(ダイヤイオ
ンHP−20,三菱化成社製)に通塔して吸着させ
水洗後、30%メタノールとメタノールそれぞれ1
を用いた直線的濃度勾配容出を行うと活性画分
が分画される。活性画分を集め濃縮乾固後、エタ
ノール:水(10:1容量比)の混合溶媒に溶解
し、同じ溶媒で充填したシリカゲル(100g)の
カラムにのせ同じ溶媒で展開するとDC−52,DC
−52−dの順で溶出されてくる。これらの含まれ
る画分をそれぞれ集めて濃縮後メタノールに溶解
し、これにエチルエーテルを加えて白色粉末を得
る。DC−52およびDC−52−dは、それぞれ10mg
および2mg得られる。
得られたDC−52およびDC−52−dの理化学的
性質、抗菌活性、抗癌活性は前記の通りである。
実施例 2
実施例1において、発酵培地組成を次のものに
代えて行なう以外は実施例1と同様に行ないDC
−52(7mg)およびDC−52−d(1mg)を得る。
発酵培地組成:グルコース50g/,
NaH2PO40,2g/,Na2HPO40.3g/,
MgSO4・7H2O0.3g/,酵母エキス7g/,
CaCO31g/,PH7.0(殺菌前)にNaOHで調整
する。
実施例 3
抗腫瘍性注射液の調整
実施例1および2で得られたDC−52の10mgを
50mlのエタノールに溶解させ、撹拌させた後エタ
ノールを吸引除去する。残査に減菌した生理的食
塩水約10mlを加え注射液とする。[Table] (B) Physiological properties The physiological properties of strain DO-52 are shown below. Regarding the effects other than temperature, milk and cellulose, the observation results after 2 weeks at 27℃ are shown.
The temperature results are shown after 5 days, and the effects on milk and cellulose are shown after 1 month. 1 Assimilation of carbon source Carbon source Assimilation D-arabinose ± D-xylose + D-glucose D-fructose Sucrose + Inositol ± L-rhamnose Raffinose + D-mannite − 2 Liquefaction of gelatin ± 3 Effect on milk Liquefaction Coagulation - Peptonization - 4 Decomposition of cellulose Slightly 5 Hydrolysis of starch Yes 6 Optimum growth pH 6.8-7.5 7 Optimum growth temperature 28-38℃ 8 Production of tyrosinase None 9 Production of melanoid pigment None Above Based on its properties, strain DO-52 is classified as an actinomycete belonging to the Streptomyces layer. Regarding the species to which this fungus belongs, E. Ku¨ster (Intern. J. System.
According to the classification by Bacteriol., Vol. 22, No. 3, p. 139, 1972), aerial mycelium is grayish, and the color of the underside of the mycelia is distinct (dark brown to black), and contains melamine pigments. The following four types are listed as those that do not produce spores, have soluble pigments, have curved or spiral-shaped sporophores, and have smooth surfaces. Streptomyces tendae, Streptomyces tendae
Streptomyces nodosus, Streptomyces cyanogenus
cyanogenus), Streptomyces violaceolatus. The shape of the sporophyte is similar to the former two, but they differ in soluble pigments and sugar assimilation. For example DO
In -52, the color does not change on the acidic side, but changes on the alkaline side, whereas the pigments of these target species change color tone on the acidic side. Furthermore, the assimilation properties of raffinose and mannitol are opposite. The latter two have slightly different shapes of sporophores, but their ability to assimilate sugars is very similar; however, the assimilation of mannitol and inositol is different, and their soluble pigments change with acid and alkali. In contrast, the pigment of DO-52 only changes on the alkaline side. (EBShirling and D.Gottlieb.Intern・J.
System.Bacteriol., 18(2)69(′68), InternJ.
System.Bacteriol., 18(4)282(′68), Intern.J.
System. Bacteriol., 19(4)391('69)) Compared to the above four species, the major differences are that the spores are cylindrical (approximately 0.4 x 0.6μ) and that the soluble pigment changes. can give. The DO-52 mauve wine (7 1/2ni) is particularly distinctive.
This is NaOH and cinnamon brown (3g)
Changes to When liquid culture is performed, this black-purple pigment is excreted outside the bacterial cells and accumulates in the medium. From this point of view, DO-52 was determined to be a new species different from any of the target bacterial strains, and was classified as Streptomyces melanobinaceus due to its characteristic pigment.
melanovinaceus DO-52). This bacterium is located at the Institute of Microbial Technology, Agency of Industrial Science and Technology, located at 1-1-3 Higashi, Yatabe-cho, Tsukuba-gun, Ibaraki Prefecture, and at Peoria, Illinois, USA.
They have been deposited with the USD Department of Agriculture and given accession numbers of FEIKEN Article No. 654 and NRRL 12388, respectively. The properties of the strains shown here can sometimes be mutated by artificial mutagenic means such as ultraviolet rays, X-rays, and chemicals, as is the case with known species belonging to the genus Streptomyces. Any mutant strain capable of producing DC-52 can be applied to the present invention. Next, I will talk about the culture method. In the cultivation of the present invention, ordinary methods for culturing actinomycetes are generally used. Various nutrient sources can be used for culturing, as shown below. As the carbon source, glucose, starch, dextrin, mannose, fructose, sucrose, lactose, xylose, arabinose, mannitol, molasses, etc. are used singly or in combination. Furthermore, depending on the assimilation ability of the bacteria, hydrocarbons, alcohols, organic acids, etc. may also be used.
As the nitrogen source, ammonium chloride, ammonium sulfate, ammonium nitrate, sodium nitrate, urea, peptone, meat extract, yeast extract, dried yeast, corn, stave, liquor, soybean flour, casamino acid, etc. are used alone or in combination. In addition, inorganic salts such as table salt, potassium chloride, magnesium sulfate, calcium carbonate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, ferrous sulfate, calcium chloride, manganese sulfate, subsulfate, copper sulfate, etc. are added as necessary. .
Furthermore, the growth of the bacteria used, DC-52 and DC-52-d
Trace ingredients that promote the production of vitamin B 1 ,
Biotin and the like can be appropriately added. As a culture method, a liquid culture method, especially a deep stirring culture method, is suitable. Culture temperature is 25-40
℃, especially 28 to 38℃, and the pH of the medium can be adjusted to PH4 to 4 by adding aqueous ammonia or ammonium carbonate solution.
It is desirable to culture at 10, preferably 6 to 8. When the liquid culture is carried out for usually 1 to 7 days, the target substances (DC-52 and DC-52-d) are produced and accumulated in the culture solution and in the bacterial cells. When the production amount in the culture reaches the maximum, the culture is stopped, the bacterial cells are separated, and the culture solution and the bacterial cells are separated. For isolation and purification of DC-52 and DC-52-d from the culture solution, conventional separation and purification methods used for isolating microbial metabolic products from the culture solution are used. For example, the culture product is separated into a culture solution and bacterial cells, and the culture solution is directly used (PH6.0) with a nonionic porous resin (for example, "Diaion PH-20" manufactured by Mitsubishi Sei Co., Ltd.). After passing through and adsorbing active ingredients, the adsorbed substances are desorbed using methanol, acetone, ethyl acetate, etc. This desorption solution is concentrated to dryness, adsorbed onto Celite powder,
DC-52 and DC-52-d can be desorbed using methanol, acetone, etc. Furthermore, solvent extraction method,
Purification is performed by combining common purification methods such as partition chromatography. Next, an example will be given. In the examples, the trends of DC-52 and DC-52-d were tracked using a bioassay using Bacillus subtilis No. 10707 or the ultraviolet absorption of DC-52 and DC-52-d. Example 1 Streptomyces mereobinaceus DO-52 was used as an inoculum. The strain was grown in a 2-volume Erlenmeyer flask as a seed medium [KCl4g/, MgSO4 .
7H 2 O 0.5g/, KH 2 PO 4 1.5g/, Ammonium sulfate 5.0
g/, sucrose 20g/, fructose
10g/, glucose 10g/, corn steep liquor 5.0g/, CaCO 3 20g/PH7.0〕300ml
The cells were inoculated and cultured at 30°C for 48 hours with shaking (220 rpm). The seed culture thus obtained was mixed into a fermentation medium 15 with the following composition in a 30-volume jar fermenter.
5% (volume) and cultured at 30° C. using an aeration agitation method (rotation speed 250 rpm, aeration rate 15/min). Fermentation medium composition: glucose 50g/,
KH 2 PO 4 0.3g/, K 2 HPO 4 0.4g/,
MgSO 4・7H 2 O0.2g/, powdered soybean meal 20g/,
CaCO 3 1g/, adjust pH to 7.0 (before sterilization) with NaOH. Culture is carried out for 72 hours without controlling the pH of the culture medium. Separate the bacterial cells and precipitate from the culture solution, and
Get 13. First, add the solution to the cation exchange resin WK−
20 (manufactured by Mitsubishi Kasei) to adsorb the active substance and wash thoroughly with water. Next, elute with 2M ammonium acetate aqueous solution 3, and leave the eluate as it is.
500ml non-ionic porous resin (Diaion
HP-20, manufactured by Mitsubishi Kasei Co., Ltd.) to adsorb the active substance and wash with 2 parts of water and 20% methanol.
Elute the active substance with 50% methanol 3. After decolorizing the eluate by adding 3 g of activated carbon, the activated carbon is separated. This was concentrated to remove methanol, and then passed through a column of 400 ml of nonionic porous resin (Diaion HP-20, manufactured by Mitsubishi Kasei Corporation) to adsorb it. After washing with water, 30% methanol and methanol
The active fraction is fractionated by linear concentration gradient evacuation. The active fractions were collected and concentrated to dryness, then dissolved in a mixed solvent of ethanol:water (10:1 volume ratio), placed on a column of silica gel (100 g) packed with the same solvent, and developed with the same solvent to give DC-52, DC.
It is eluted in the order of -52-d. These fractions are collected and concentrated, then dissolved in methanol, and ethyl ether is added to obtain a white powder. DC-52 and DC-52-d were each 10 mg
and 2 mg are obtained. The physicochemical properties, antibacterial activity, and anticancer activity of the obtained DC-52 and DC-52-d are as described above. Example 2 The same procedure as in Example 1 was carried out except that the composition of the fermentation medium was changed to the following.
-52 (7 mg) and DC-52-d (1 mg) are obtained. Fermentation medium composition: glucose 50g/,
NaH 2 PO 4 0.2g/, Na 2 HPO 4 0.3g/,
MgSO 4・7H 2 O0.3g/, yeast extract 7g/,
CaCO 3 1g/, adjust pH to 7.0 (before sterilization) with NaOH. Example 3 Preparation of antitumor injection solution 10 mg of DC-52 obtained in Examples 1 and 2 was
Dissolve in 50 ml of ethanol, stir, and remove the ethanol by suction. Add about 10 ml of sterile physiological saline to the residue to make an injection solution.
第1図はDC−52の紫外部吸収スペクトルを示
す。第2図はDC−52の赤外部吸収スペクトルを
示す。第3図はDC−52のPMRスペクトルを示
す。第4図はDC−52−dのPMRスペクトルを示
す。
Figure 1 shows the ultraviolet absorption spectrum of DC-52. Figure 2 shows the infrared absorption spectrum of DC-52. Figure 3 shows the PMR spectrum of DC-52. Figure 4 shows the PMR spectrum of DC-52-d.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56054824A JPS57170189A (en) | 1981-04-11 | 1981-04-11 | Dc-52 and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56054824A JPS57170189A (en) | 1981-04-11 | 1981-04-11 | Dc-52 and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57170189A JPS57170189A (en) | 1982-10-20 |
JPS6361952B2 true JPS6361952B2 (en) | 1988-11-30 |
Family
ID=12981423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56054824A Granted JPS57170189A (en) | 1981-04-11 | 1981-04-11 | Dc-52 and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57170189A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59210086A (en) * | 1983-05-13 | 1984-11-28 | Kyowa Hakko Kogyo Co Ltd | Dx-52-1 compound and its preparation |
JPS60197690A (en) * | 1984-03-16 | 1985-10-07 | Kyowa Hakko Kogyo Co Ltd | Salt of dc-52 |
JPS6388183A (en) * | 1986-10-01 | 1988-04-19 | Kyowa Hakko Kogyo Co Ltd | Dc-52 type antitumor compound |
US4822882A (en) * | 1986-10-03 | 1989-04-18 | Kyowa Hakko Kogyo Co., Ltd. | DC-52 derivatives and their antitumor use |
JP2569358B2 (en) * | 1988-11-16 | 1997-01-08 | 協和醗酵工業株式会社 | New compound |
-
1981
- 1981-04-11 JP JP56054824A patent/JPS57170189A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS57170189A (en) | 1982-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4923990A (en) | Pyrindamycins A and B and duocarmycin A antibiotics derived from certain streptomyces culture | |
EP0132082B1 (en) | Antibiotic/antitumor compounds and their production | |
JPH02177890A (en) | New substance dc113 and production thereof | |
EP0182315A2 (en) | Novel antibiotic NK84-0218 pharmaceutical compositions containing it and process for the production of the same | |
GB1589536A (en) | Antitumor anthracycline antibiotics | |
CA1270782A (en) | Cl-1577d and 1577e antibiotic/antitumor compounds, their production and use | |
JPS6361952B2 (en) | ||
JPS61236792A (en) | Novel anthracycline antibiotic | |
JPH01246288A (en) | Tan-1030a and its derivative, production and use thereof | |
JPH0576958B2 (en) | ||
JPS6330916B2 (en) | ||
JP2594085B2 (en) | SF2575, a new antitumor antibiotic, and method for producing the same | |
JP3112342B2 (en) | New compound UCE6 | |
US5468637A (en) | S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones | |
JP3148331B2 (en) | Antibiotics respinomycin, method for producing the same, and antitumor and antiviral agents | |
JPH04145074A (en) | Diterpene compound and production thereof | |
JPS6317075B2 (en) | ||
JPS61285992A (en) | Antitumor antibiotic mf730-n6 and production thereof | |
JPS6253518B2 (en) | ||
JPS5915634B2 (en) | Production method of actinomycin by fermentation method | |
JP2000086627A (en) | Antibacterial substance be-54476 and its production | |
JPH039110B2 (en) | ||
JPH06199882A (en) | New antifungal antibiotic substance w7176b and w7176c and production thereof | |
JPS6253519B2 (en) | ||
JPH0571599B2 (en) |